Bain Capital Specialty Finance, Inc. — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022; unaudited. Bain Capital Specialty Finance is an externally managed business development company (BDC) focused primarily on senior secured lending to middle-market companies. Amounts below are in U.S. dollars; financial statement figures are in millions unless stated otherwise.
Key financial results
| Metric | Q2 2022 | Q2 2021 | First half 2022 | First half 2021 |
|---|---|---|---|---|
| Investment income | $52.4 | $46.5 | $98.4 | $96.3 |
| Net investment income | $26.7 | $21.9 | $48.4 | $44.1 |
| Net increase in net assets from operations | $17.2 | $42.4 | $50.9 | $74.2 |
| Net investment income per share | $0.41 | $0.34 | $0.75 | $0.68 |
| Operations per share | $0.27 | $0.66 | $0.79 | $1.15 |
- Q2 investment income rose 13% year over year, while net investment income rose 22%. Higher dividend and other income offset lower interest income. Other income included increased one-time fees.
- Q2 operating results declined year over year, principally reflecting net unrealized depreciation of investments. For the quarter, total realized and unrealized results were a $9.5 million loss, compared with a $20.5 million gain in Q2 2021. Management attributed 2022 valuation pressure primarily to wider credit spreads and negative valuation adjustments.
- For the first half, net investment income improved, but operations declined as net realized and unrealized gains fell to $2.5 million from $30.1 million a year earlier.
- Annualized first-half net investment income to average net assets was 9.51%; total net expenses to average net assets were 8.43%. These ratios are not directly comparable to conventional operating-company margins.
Financial position, liquidity and portfolio
- At June 30, 2022, net assets were $1.107 billion and NAV was $17.15 per share, up from $1.100 billion and $17.04 at December 31, 2021. The period-end market price was $13.61 per share.
- Investment fair value was $2.287 billion versus $2.289 billion at year-end. First-lien senior secured loans represented 71.4% of investment fair value. The portfolio included 122 companies; 94.8% of debt investments by fair value bore floating rates.
- Debt principal outstanding was $1.257 billion, down from $1.431 billion at year-end; carrying value, net of issuance costs, was $1.244 billion. The combined weighted-average borrowing rate for the first half was 3.0%. Asset coverage was 188%, compared with 177% at year-end.
- Cash, foreign cash and restricted cash totaled $68.9 million, down from $203.6 million at year-end. The company reported $108.3 million of availability on its $300 million Sumitomo facility and $50 million under its undrawn advisor revolver at June 30.
- First-half operating cash flow was negative $280.2 million, largely reflecting $761.8 million of investment purchases against $434.2 million of investment repayments and sales. Financing activities provided $146.7 million. Cash distributions paid were $43.9 million.
- Unfunded investment commitments totaled $283.3 million, up from $234.0 million at year-end; funding is generally subject to borrower conditions.
- Three loans to one issuer were on non-accrual at June 30, versus no non-accrual loans at year-end. These investments had $32.6 million fair value, or 1.4% of portfolio fair value. One additional issuer was rated 3 and eight were rated 3 overall; one issuer was rated 4, under the company’s internal scale.
Changes, distributions and unusual items
- Management reported that first-half investment purchases of $859.2 million were nearly offset by $853.4 million of repayments and sales. The portfolio expanded to 122 companies from 106 at year-end.
- The company formed Senior Loan Program, LLC (SLP) with Amberstone and sold 70% of its 2018-1 CLO interests to SLP, deconsolidating that vehicle. It received $56.1 million in proceeds and recorded a $1.2 million realized gain. The filing also describes its international loan joint venture, ISLP, with Pantheon.
- Quarterly distributions remained $0.34 per share; $0.68 per share was declared for the first half, the same as in 2021. The July 29, 2022 payment was declared before quarter-end.
- After quarter-end, Sumitomo facility commitments were increased from $300 million to $385 million on July 6 and then to $485 million on July 22. The amendments also replaced LIBOR benchmark provisions with SOFR provisions.
- Restricted securities had aggregate fair value of $342.2 million, reported as 20.91% of NAV. Non-qualifying assets were 26.61% of total assets, below the BDC limit requiring at least 70% of assets to be qualifying assets.
Outlook, risks and contingencies
- The filing provides no formal earnings or distribution guidance. Management says investment activity depends on market conditions, available capital, competition and other factors; future results are uncertain.
- Key exposures include credit deterioration among borrowers, illiquid investments and valuation uncertainty; most investments use Level 3 inputs. Higher comparative yields or discount rates can reduce estimated fair values.
- Floating-rate assets may benefit from higher base rates, but higher rates can also increase borrowers’ debt-service burdens and the company’s financing costs. The filing’s sensitivity analysis estimates that a 100-basis-point rate increase would raise annualized net investment income by $9.9 million, assuming the balance sheet and positions remain unchanged.
- Foreign-currency movements, derivatives and counterparty performance create additional risks. The company uses forward contracts but does not assure that hedging will be effective.
- Management discusses uncertainty from Russia’s invasion of Ukraine and related sanctions and market disruption. It reported no material changes to the previously disclosed risk factors during the quarter. No material legal proceedings were reported.
- The company reported compliance with the Sumitomo facility and 2019-1 debt covenants at June 30. It cautions that forward-looking statements are not guarantees and undertakes no general obligation to update them.
Important facts for investors to verify
- Review the identity, payment status, collateral and recovery assumptions for the three non-accrual loans and the issuer rated 4.
- Assess the largest valuation declines, Level 3 assumptions and the effect of wider credit spreads on NAV.
- Confirm the 2023 Notes maturity and refinancing plan, facility availability and covenants, and the impact of the post-quarter Sumitomo upsizes and SOFR transition.
- Evaluate the $283.3 million of unfunded commitments alongside cash, restricted cash and liquidity needs, including distributions.
- Check the performance, leverage, commitments and valuation of ISLP and SLP, including the company’s related-party and joint-venture exposures.
- Compare the $13.61 market price with $17.15 NAV per share and verify the distribution’s tax characterization when finalized.